Safety and Efficacy Study of Topical Administration of FOV2304 (High Dose or Low Dose) for the Treatment of Center-involving Clinically Significant Macular Edema Associated With Diabetic Retinopathy
Clinical trial NCT01319487 · COMPLETED
Trial details
- NCT number
- NCT01319487
- Sponsor
- Fovea Pharmaceuticals SA
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2012-03-01
- Enrollment
- 267
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.